Tumor necrosis factor-α inhibits generation of glycophorin A+ cells by CD34+ cells

Experimental Hematology

Volumn 30, Issue 11, 2002, Pages 1238-1247

  Xiao, Weiguo ^a,b   Koizumi, Kazuki ^a   Nishio, Mitsufumi ^a   Endo, Tomoyuki ^a   Osawa, Mitsujiro ^c   Fujimoto, Katsuya ^a   Sato, Ikumi ^a,d   Sakai, Toshiya ^a   Koike, Takao ^a   Sawada, Ken Ichi ^a,d  

^a HOKKAIDO UNIVERSITY   (Japan)

^b CHINA MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF TOKYO   (Japan)

^d AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPHORIN A; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT INTERLEUKIN 3; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; STEM CELL FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; CELL PROLIFERATION; COLONY FORMING UNIT E; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ERYTHROID PRECURSOR CELL; ERYTHROPOIESIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PURIFICATION; SIGNAL TRANSDUCTION;

ADULT; ANTIGENS, CD; ANTIGENS, CD34; ANTIGENS, DIFFERENTIATION; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; COLONY-FORMING UNITS ASSAY; ERYTHROID PROGENITOR CELLS; ERYTHROPOIESIS; FILGRASTIM; GLYCOPHORIN; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; TUMOR NECROSIS FACTOR-ALPHA;

EID: 18644366894     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(02)00930-X     Document Type: Article

References (49)

1. Lee G.R. The anemia of chronic disease. Semin Hematol. 20:1983;61.
2. Roodman G.D., Bird A., Hutzler D., Montgomery W. Tumor necrosis factor-α and hematopoietic progenitors. effects of tumor necrosis factor on the growth of erythroid progenitors CFU-E and BFU-E and the hematopoietic cell lines K562, HL60, and HEL cells Exp Hematol. 15:1987;928.
3. Johnson R.A., Waddelow T.A., Caro J., Oliff A., Roodman G.D. Chronic exposure to tumor necrosis factor in vivo preferentially inhibits erythropoiesis in nude mice. Blood. 74:1989;130.
4. Sugarman B.J., Aggarwal B.B., Hass P.E., Figari I.S., Palladino M.A. Jr., Shepard H.M. Recombinant human tumor necrosis factor-α effects on proliferation of normal and transformed cells in vitro Science. 230:1985;943.
5. Vilcek J., Palombella V.J., Henriksen-DeStefano D.et al. Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors. J Exp Med. 163:1986;632.
6. Nawroth P.P., Stern D.M. Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med. 163:1986;740.
7. Shalaby M.R., Aggarwal B.B., Rinderknecht E., Svedersky L.P., Finkle B.S., Palladino M.A. Jr. Activation of human polymorphonuclear neutrophil functions by interferon-γ and tumor necrosis factors. J Immunol. 135:1985;2069.
8. Kelker H.C., Oppenheim J.D., Stone-Wolff D.et al. Characterization of human tumor necrosis factor produced by peripheral blood monocytes and its separation from lymphotoxin. Int J Cancer. 36:1985;69.
9. Cuturi M.C., Murphy M., Costa-Giomi M.P., Weinmann R., Perussia B., Trinchieri G. Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes. J Exp Med. 165:1987;1581.
10. Degliantoni G., Murphy M., Kobayashi M., Francis M.K., Perussia B., Trinchieri G. Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor. Relationship with tumor necrosis factor and synergism with immune interferon. J Exp Med. 162:1985;1512.
11. Broxmeyer H.E., Williams D.E., Lu L.et al. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia. synergism of tumor necrosis factor and interferon-γ J Immunol. 136:1986;4487.
12. Murase T., Hotta T., Saito H., Ohno R. Effect of recombinant human tumor necrosis factor on the colony growth of human leukemia progenitor cells and normal hematopoietic progenitor cells. Blood. 69:1987;467.
13. Murphy M., Perussia B., Trinchieri G. Effects of recombinant tumor necrosis factor, lymphotoxin, and immune interferon on proliferation and differentiation of enriched hematopoietic precursor cells. Exp Hematol. 16:1988;131.
14. Backx B., Broeders L., Bot F.J., Lowenberg B. Positive and negative effects of tumor necrosis factor on colony growth from highly purified normal marrow progenitors. Leukemia. 5:1991;66.
15. Caux C., Favre C., Saeland S.et al. Potentiation of early hematopoiesis by tumor necrosis factor-α is followed by inhibition of granulopoietic differentiation and proliferation. Blood. 78:1991;635.
16. Caux C., Saeland S., Favre C., Duvert V., Mannoni P., Banchereau J. Tumor necrosis factor-α strongly potentiates interleukin-3 and granulocyte-macrophage colony-stimulating factor-induced proliferation of human CD34+ hematopoietic progenitor cells. Blood. 75:1990;2292.
17. Caux C., Durand I., Moreau I., Duvert V., Saeland S., Banchereau J. Tumor necrosis factor α cooperates with interleukin 3 in the recruitment of a primitive subset of human CD34+ progenitors. J Exp Med. 177:1993;1815.
18. Rusten L.S., Jacobsen F.W., Lesslauer W., Loetscher H., Smeland E.B., Jacobsen S.E. Bifunctional effects of tumor necrosis factor α (TNF α) on the growth of mature and primitive human hematopoietic progenitor cells. involvement of p55 and p75 TNF receptors Blood. 83:1994;3152.
19. Jacobsen S.E., Ruscetti F.W., Dubois C.M., Keller J.R. Tumor necrosis factor α directly and indirectly regulates hematopoietic progenitor cell proliferation. role of colony-stimulating factor receptor modulation J Exp Med. 175:1992;1759.
20. Rusten L.S., Jacobsen S.E. Tumor necrosis factor (TNF)-α directly inhibits human erythropoiesis in vitro. role of p55 and p75 TNF receptors Blood. 85:1995;989.
21. Munker R., Gasson J., Ogawa M., Koeffler H.P. Recombinant human TNF induces production of granulocyte-monocyte colony-stimulating factor. Nature. 323:1986;79.
22. Oster W., Lindemann A., Horn S., Mertelsmann R., Herrmann F. Tumor necrosis factor (TNF)-α but not TNF-β induces secretion of colony stimulating factor for macrophages (CSF-1) by human monocytes. Blood. 70:1987;1700.
23. Koeffler H.P., Gasson J., Ranyard J., Souza L., Shepard M., Munker R. Recombinant human TNF α stimulates production of granulocyte colony-stimulating factor. Blood. 70:1987;55.
24. Means R.T. Jr., Dessypris E.N., Krantz S.B. Inhibition of human colony-forming-unit erythroid by tumor necrosis factor requires accessory cells. J Clin Invest. 86:1990;538.
25. Means R.T. Jr., Krantz S.B. Inhibition of human erythroid colony-forming units by tumor necrosis factor requires β interferon. J Clin Invest. 91:1993;416.
26. Blick M., Sherwin S.A., Rosenblum M., Gutterman J. Phase I study of recombinant tumor necrosis factor in cancer patients. Cancer Res. 47:1987;2986.
27. Li X.F., Anderson J., Hutzler D., Roodman G.D. Hemin-induced erythroid differentiation changes the sensitivity of K562 cells to tumor necrosis factor-α Exp Hematol. 17:1989;1059.
28. Oda A., Sawada K., Druker B.J.et al. Erythropoietin induces tyrosine phosphorylation of Jak2, STAT5A, and STAT5B in primary cultured human erythroid precursors. Blood. 92:1998;443.
29. Sato N., Sawada K., Takahashi T.A.et al. A time course study for optimal harvest of peripheral blood progenitor cells by granulocyte colony stimulating factor in healthy volunteers. Exp Hematol. 22:1994;973.
30. + cells. Use of immunomagnetic microspheres. Bone Marrow Transplant. 19:1997;373.
31. Sawada K., Krantz S.B., Dai C.H.et al. Purification of human blood burst forming units erythroid and demonstration of the evolution of erythropoietin receptors. J Cell Physiol. 142:1993;219.
32. McLeod D.L., Shreeve M.M., Axelrad A.A. Improved plasma culture system for production of erythrocytic colonies in vitro. Quantitative assay method for CFU-E. Blood. 44:1974;517.
33. Sawada K., Krantz S.B., Dessypris E.N., Koury S.T., Sawyer S.T. Human colony forming units erythroid do not require accessory cells, but do require direct interaction with insulin like growth factor I and/or insulin for erythroid development. J Clin Invest. 83:1989;1701.
34. Schall T.J., Lewis M., Koller K.J.et al. Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell. 61:1990;361.
35. Loetscher H., Pan Y.C., Lahm H.W.et al. Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell. 61:1990;351.
36. Heller R.A., Song K., Onasch M.A., Fischer W.H., Chang D., Ringold G.M. Complementary DNA cloning of a receptor for tumor necrosis factor and demonstration of a shed form of the receptor. Proc Natl Acad Sci U S A. 87:1990;6151.
37. Dembic Z., Loetscher H., Gubler U.et al. Two human TNF receptors have similar extracellular, but distinct intracellular, domain sequences. Cytokine. 2:1990;231.
38. Smith C.A., Davis T., Anderson D.et al. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science. 248:1990;1019.
39. Sato T., Selleri C., Anderson S., Young N.S., Maciejewski J.P. Expression and modulation of cellular receptors for interferon-γ, tumour necrosis factor, and Fas on human bone marrow CD34+ cells. Br J Haematol. 97:1997;356.
40. Baglioni C., McCandless S., Tavernier J., Fiers W. Binding of human tumor necrosis factor to high affinity receptors on HeLa and lymphoblastoid cells sensitive to growth inhibition. J Biol Chem. 260:1985;13395.
41. Kull F.C. Jr., Jacobs S., Cuatrecasas P. Cellular receptor for 125I-labeled tumor necrosis factor. specific binding, affinity labeling, and relationship to sensitivity Proc Natl Acad Sci U S A. 82:1985;5756.
42. Tsujimoto M., Yip Y.K., Vilcek J. Tumor necrosis factor. specific binding and internalization in sensitive and resistant cells Proc Natl Acad Sci U S A. 82:1985;7626.
43. Lehmann V., Droge W. Demonstration of membrane receptors for human natural and recombinant 125I-labeled tumor necrosis factor on HeLa cell clones and their role in tumor cell sensitivity. Eur J Biochem. 158:1986;1.
44. Idriss H.T., Naismith J.H. TNF α and the TNF receptor superfamily. structure-function relationship(s) Microsc Res Tech. 50:2000;184.
45. Pimentel-Muinos F.X., Seed B. Regulated commitment of TNF receptor signaling. a molecular switch for death or activation Immunity. 11:1999;783.
46. Grell M., Zimmermann G., Gottfried E.et al. Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30. a role for TNF-R1 activation by endogenous membrane-anchored TNF EMBO J. 18:1999;3034.
47. Oliveira Pinto L.M., Garcia S., Lecoeur H., Rapp C., Gougeon M.-L. Increased sensitivity of T lymphocytes to tumor necrosis factor receptor 1 (TNFR1)- and TNFR2-mediated apoptosis in HIV infection. relation to expression of Bcl-2 and active caspase-8 and caspase-3 Blood. 99:2002;1666.
48. Kapur R., Zhang L. A novel mechanism of cooperation between c-Kit and erythropoietin receptor. Stem cell factor induces the expression of Stat. 5(and erythropoietin receptor, resulting in efficient proliferation and survival by erythropoietin. J Biol Chem 276):2001;1099.
49. Gregoli P.A., Bondurant M.C. The roles of Bcl-xL and apopain in the control of erythropoiesis by erythropoietin. Blood. 90:1997;630.